Mr. Linnen joined The Jordan Company in 1993. For the first ten years at TJC, Mr. Linnen focused on sourcing, originating, evaluating, negotiating and leading the execution of acquisition transactions. Since 2003, he has focused all of his time on sourcing, originating and evaluating transactions on behalf of TJC. He currently serves on the board of directors for Worldwide Clinical Trials, Inc. Mr. Linnen is Chairman Emeritus of the La Lumiere School Board of Trustees and he is currently Co-Chair of its Courageous Vision Capital Campaign. Mr. Linnen holds a B.S. degree in Business Administration with concentration in Finance from the University of Notre Dame.